Bangalore is "crucial site" for biotech development in India

16 February 2009

Technology Vision Group, a leading producer of international biotechnology partnering meetings, has teamed up with MM Activ, India's  leading science technology communication firm, to launch a joint  collaboration to enable foreign life science companies to expand into  India. "The new initiative is called BioPartnering@BangaloreBio 2009,  and is aimed at making it easy for life science companies to meet their  Indian counterparts in a professional and organized atmosphere," the  companies said in a joint statement. BangaloreBio 2009 is intended to be  India's largest and most successful biotechnology and pharmaceutical  conference and will take place in June.

Robert Lee Kilpatrick, a partner at TVG, said: "India is strategically  important to our clients because it is an important and growing part of  the global value chain for health care companies. Biotechnology and  pharmaceutical companies seek opportunities in India including markets,  production, skilled workers, technology and capital. In this regard,  India has it all."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight